Eric M. Vela

548 total citations
26 papers, 445 citations indexed

About

Eric M. Vela is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Eric M. Vela has authored 26 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 10 papers in Epidemiology and 5 papers in Virology. Recurrent topics in Eric M. Vela's work include Viral Infections and Outbreaks Research (10 papers), Viral gastroenteritis research and epidemiology (6 papers) and Viral Infections and Vectors (6 papers). Eric M. Vela is often cited by papers focused on Viral Infections and Outbreaks Research (10 papers), Viral gastroenteritis research and epidemiology (6 papers) and Viral Infections and Vectors (6 papers). Eric M. Vela collaborates with scholars based in United States, Canada and Japan. Eric M. Vela's co-authors include Judith F. Aronson, Robert A. Davey, Norbert K. Herzog, Gavin C. Bowick, Lihong Zhang, Tonya M. Colpitts, Alexis L. Thompson, Christopher J. Pursell, Andrey A. Kolokoltsov and James P. Long and has published in prestigious journals such as PLoS ONE, Journal of Virology and Scientific Reports.

In The Last Decade

Eric M. Vela

26 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric M. Vela United States 12 184 123 92 73 63 26 445
Antra Zeltina United Kingdom 12 365 2.0× 203 1.7× 161 1.8× 23 0.3× 76 1.2× 16 628
Jonathan J. Madara United States 8 125 0.7× 174 1.4× 156 1.7× 88 1.2× 24 0.4× 8 432
Peiqi Yin China 10 89 0.5× 91 0.7× 142 1.5× 40 0.5× 16 0.3× 29 341
Ralf Bartenschlager Germany 7 333 1.8× 261 2.1× 248 2.7× 168 2.3× 48 0.8× 9 813
Bastian Thaa Germany 13 162 0.9× 216 1.8× 274 3.0× 75 1.0× 129 2.0× 15 528
Eric M. Jurgens United States 10 126 0.7× 224 1.8× 78 0.8× 25 0.3× 50 0.8× 13 352
Rei Matsuoka Japan 12 148 0.8× 161 1.3× 269 2.9× 39 0.5× 77 1.2× 14 595
Célia Caillet‐Saguy France 16 138 0.8× 108 0.9× 333 3.6× 50 0.7× 56 0.9× 27 583
L V von Stedingk Sweden 10 103 0.6× 92 0.7× 157 1.7× 83 1.1× 30 0.5× 27 451
Jenna N. Kelly Switzerland 10 224 1.2× 97 0.8× 149 1.6× 141 1.9× 45 0.7× 15 474

Countries citing papers authored by Eric M. Vela

Since Specialization
Citations

This map shows the geographic impact of Eric M. Vela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric M. Vela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric M. Vela more than expected).

Fields of papers citing papers by Eric M. Vela

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric M. Vela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric M. Vela. The network helps show where Eric M. Vela may publish in the future.

Co-authorship network of co-authors of Eric M. Vela

This figure shows the co-authorship network connecting the top 25 collaborators of Eric M. Vela. A scholar is included among the top collaborators of Eric M. Vela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric M. Vela. Eric M. Vela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tweedell, Rebecca E., Vincent O. Nyasembe, Abhai K. Tripathi, et al.. (2021). Immunofocusing humoral immunity potentiates the functional efficacy of the AnAPN1 malaria transmission-blocking vaccine antigen. npj Vaccines. 6(1). 49–49. 13 indexed citations
2.
Vela, Eric M., et al.. (2020). Development of a high-yield live-virus vaccine production platform using a novel fixed-bed bioreactor. Vaccine. 38(20). 3639–3645. 11 indexed citations
3.
Cirimotich, Chris M., et al.. (2017). Chikungunya virus infection in Cynomolgus macaques following Intradermal and aerosol exposure. Virology Journal. 14(1). 135–135. 5 indexed citations
4.
Stark, Gregory V., James P. Long, Diana I. Ortiz, et al.. (2013). Clinical Profiles Associated with Influenza Disease in the Ferret Model. PLoS ONE. 8(3). e58337–e58337. 28 indexed citations
5.
Vela, Eric M., et al.. (2012). The Syrian Golden Hamster as a Model to Study Flexal Virus Pathogenesis. 3(2). 3 indexed citations
6.
Long, James P., et al.. (2012). Early Indicators of Disease in Ferrets Infected with a High Dose of Avian Influenza H5N1. Scientific Reports. 2(1). 972–972. 7 indexed citations
7.
Gibson, P.N., et al.. (2012). Implantation and Monitoring of a Novel Telemetry Unit in the Syrian Golden Hamster Model. Journal of Investigative Surgery. 25(3). 186–196. 3 indexed citations
8.
Vela, Eric M.. (2012). Animal Models, Prophylaxis, and Therapeutics for Arenavirus Infections. Viruses. 4(9). 1802–1829. 26 indexed citations
9.
Kolokoltsov, Andrey A., et al.. (2011). Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin. Archives of Virology. 157(1). 121–127. 36 indexed citations
10.
Vela, Eric M., et al.. (2011). Efficacy of a heterologous vaccine and adjuvant in ferrets challenged with influenza virus H5N1. Influenza and Other Respiratory Viruses. 6(5). 328–340. 6 indexed citations
12.
Vela, Eric M., et al.. (2010). The disease progression associated with pirital virus infection in the Syrian golden hamster. 2(1). 15–23. 4 indexed citations
14.
Vela, Eric M., et al.. (2008). Developmental Regulation of Neuregulin1 Isoforms and erbB Receptor Expression in Intact Rat Dorsal Root Ganglia. Neurochemical Research. 34(1). 17–22. 11 indexed citations
15.
Vela, Eric M., Tonya M. Colpitts, Lihong Zhang, Robert A. Davey, & Judith F. Aronson. (2008). Pichindé virus is trafficked through a dynamin 2 endocytic pathway that is dependent on cellular Rab5- and Rab7-mediated endosomes. Archives of Virology. 153(7). 1391–1396. 9 indexed citations
16.
Vela, Eric M., Gavin C. Bowick, Norbert K. Herzog, & Judith F. Aronson. (2008). Exploring Kinase Inhibitors as Therapies for Human Arenavirus Infections. Future Virology. 3(3). 243–251. 9 indexed citations
17.
Hossain, Md. Moyazzem, et al.. (2007). Critical role of Arg59 in the high-affinity gp120-binding region of CD4 for human immunodeficiency virus type 1 infection. Virology. 363(1). 69–78. 6 indexed citations
18.
Vela, Eric M., Gavin C. Bowick, Norbert K. Herzog, & Judith F. Aronson. (2007). Genistein treatment of cells inhibits arenavirus infection. Antiviral Research. 77(2). 153–156. 53 indexed citations
19.
Hollander, Petra den, et al.. (2007). Dynein light chain 1 peptide inhibits human immunodeficiency virus infection in eukaryotic cells. Biochemical and Biophysical Research Communications. 363(4). 901–907. 14 indexed citations
20.
Vela, Eric M., Lihong Zhang, Tonya M. Colpitts, Robert A. Davey, & Judith F. Aronson. (2007). Arenavirus entry occurs through a cholesterol-dependent, non-caveolar, clathrin-mediated endocytic mechanism. Virology. 369(1). 1–11. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026